TrialDiabetes care2013

Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.

Carolina Solis-Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.